YOLFTbeta
60

Beihai Gofar Marine Biological Industry Co Ltd

600538 · SHG · Basic Materials / Agricultural Inputs

4.59CNY+0.07 (+1.55%)

Price History

Full chart

Market Stats

Previous Close4.52
Open4.52
Day Range4.47 – 4.69
52-Week Range4.19 – 7.70
Volume14.71M
Market Cap2.51B
P/E (TTM)0.00
Forward P/E161.29
EPS-0.18
Dividend Yield0.00%
Beta0.20
50-Day Avg4.99
200-Day Avg6.04

About

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, pharmacies, health centers, clinics, directly operated stores, general agents, distributors, and allocations. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; brand gastrointestinal granules, honeysuckle oral solution, and children's syrup under the Guofa brand; and traumatic injury medicated wine, and sea snake medicated wine under the Haima brand. In addition, the company produces and sells forensic DNA testing equipment, reagents, and consumables; and provides technical services, including DNA testing services. Further, it engages in culture and arts activities; and provision of technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Zhi Bo Yin
  • Employees438
  • HeadquartersNo.3 Beibuwan Middle Road, Beihai, China, 536000, China
  • Websitehttps://www.gofar.com.cn

Leadership

  • Mr. Zhi Bo YinCFO, VP & Director · b. 1967
  • Mr. Yong LiSecretary, VP & Employee Director · b. 1965
  • Mr. Fang Cai ChengChairman of the Board & President · b. 1987
  • Binbin LiAccounting Supervisor

Financials

Income Statement

Currency: CNY1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue64.18M81.44M94.06M99.01M231.16M373.38M462.00M539.19M789.65M325.97M241.32M363.30M528.70M542.98M452.42M415.41M506.41M263.22M232.06M224.52M251.15M267.70M424.72M459.68M369.15M340.47M328.24M
Growth (%)-+26.90%+15.49%+5.27%+133.48%+61.52%+23.74%+16.71%+46.45%-58.72%-25.97%+50.55%+45.53%+2.70%-16.68%-8.18%+21.90%-48.02%-11.84%-3.25%+11.86%+6.59%+58.65%+8.23%-19.69%-7.77%-3.59%
Cost of Revenue20.54M28.97M34.48M38.10M128.19M256.53M328.72M419.13M611.02M295.33M210.55M317.23M455.53M467.94M383.61M372.30M423.27M219.92M191.07M180.63M206.38M201.84M316.59M332.98M279.46M254.68M254.49M
Gross Profit43.64M52.47M59.58M60.91M102.97M116.85M133.28M120.06M178.64M30.64M30.77M46.07M73.17M75.04M68.81M43.11M83.14M43.30M40.99M43.89M44.77M65.86M108.12M126.71M89.70M85.78M73.75M
Gross Margin68.00%64.43%63.34%61.52%44.55%31.30%28.85%22.27%22.62%9.40%12.75%12.68%13.84%13.82%15.21%10.38%16.42%16.45%17.66%19.55%17.83%24.60%25.46%27.56%24.30%25.20%22.47%
Operating Expense23.68M28.49M33.73M36.96M70.62M91.80M109.45M136.23M154.03M198.24M175.87M108.78M111.18M131.07M91.68M100.39M76.16M56.36M52.97M64.60M35.20M57.04M92.97M84.42M167.46M177.47M96.88M
Operating Income19.96M23.99M25.85M23.96M32.35M25.06M23.83M-16.17M24.61M-167.60M-145.10M-62.71M-38.01M-56.03M-22.88M-57.28M6.99M-13.06M-11.98M-20.70M9.57M8.82M15.16M42.28M-77.76M-91.69M-23.13M
Operating Margin31.10%29.45%27.49%24.20%14.00%6.71%5.16%-3.00%3.12%-51.42%-60.13%-17.26%-7.19%-10.32%-5.06%-13.79%1.38%-4.96%-5.16%-9.22%3.81%3.30%3.57%9.20%-21.07%-26.93%-7.05%
EBITDA22.45M26.71M33.98M32.77M46.96M61.42M88.05M58.85M92.71M8.44M-28.24M92.12M2.49M-62.43M42.34M-28.82M38.63M17.29M34.88M-7.41M25.93M21.17M29.52M55.69M-63.23M-76.15M-64.43M
EBITDA Margin34.98%32.79%36.12%33.10%20.32%16.45%19.06%10.91%11.74%2.59%-11.70%25.36%0.47%-11.50%9.36%-6.94%7.63%6.57%15.03%-3.30%10.32%7.91%6.95%12.12%-17.13%-22.37%-19.63%
Net Income16.22M15.61M24.59M23.69M28.09M16.21M17.74M-30.22M3.04M-176.71M-138.43M16.40M-39.04M-109.57M10.69M-49.20M4.05M-31.86M8.85M-21.61M5.77M3.20M10.49M34.84M-82.31M-93.85M-87.62M
Net Income Margin25.27%19.16%26.15%23.93%12.15%4.34%3.84%-5.60%0.38%-54.21%-57.36%4.52%-7.38%-20.18%2.36%-11.84%0.80%-12.10%3.81%-9.63%2.30%1.20%2.47%7.58%-22.30%-27.57%-26.69%
R&D-------------3.21M4.10M1.11M1.19M1.91M949.16K250.32K75.57K50.13K9.14M8.38M12.76M8.49M7.40M
R&D as % of Total Revenue-------------0.59%0.91%0.27%0.23%0.73%0.41%0.11%0.03%0.02%2.15%1.82%3.46%2.49%2.25%
Interest Expense2.49M2.87M3.38M3.23M7.57M25.11M34.36M41.85M42.78M65.98M78.67M37.66M9.62M12.15M6.55M11.66M3.78M3.71M6.54M87.02K98.22K216.45K715.56K558.14K451.59K2.48M2.43M
Interest Expense % of Total Revenue3.88%3.52%3.59%3.27%3.28%6.73%7.44%7.76%5.42%20.24%32.60%10.37%1.82%2.24%1.45%2.81%0.75%1.41%2.82%0.04%0.04%0.08%0.17%0.12%0.12%0.73%0.74%

Balance Sheet

Currency: CNY1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets166.95M195.98M206.66M235.22M740.21M1.05B1.27B1.30B1.31B1.21B943.42M706.76M696.54M613.98M690.74M991.16M984.02M957.71M776.75M763.38M750.05M1.07B1.08B1.14B1.06B966.75M896.82M
Total Liabilities67.83M90.50M76.51M87.69M261.34M523.05M716.35M771.73M815.31M881.78M736.06M481.29M504.93M522.38M579.21M261.57M246.18M268.93M117.57M125.82M104.44M214.15M160.16M182.17M176.22M179.36M196.03M
Total Equity99.09M104.83M129.42M142.04M457.14M480.81M498.55M470.09M475.40M306.51M159.79M176.76M137.71M28.15M44.48M678.13M682.19M650.32M659.18M637.56M645.61M844.42M916.70M951.56M869.24M775.39M687.78M
Cash12.69M18.95M27.75M22.70M220.96M104.23M210.00M176.17M31.35M6.56M61.06M40.88M24.73M34.21M41.47M332.19M136.16M70.98M185.33M114.22M232.30M211.35M190.40M170.86M155.26M144.84M150.77M
Total Debt35.15M49.50M51.65M48.00M193.02M434.53M603.14M552.60M603.05M594.40M474.38M148.60M171.88M54.13M65.80M44.20M36.00M33.80M7.61M3.09M11.56M15.34M6.46M14.52M15.81M36.38M-
Net Debt22.46M30.55M23.90M25.30M-27.94M330.29M393.14M376.42M571.70M587.85M413.33M107.72M147.15M19.91M24.33M-287.99M-100.16M-37.18M-177.73M-111.13M-220.74M-196.01M-183.95M-156.34M-139.45M-108.46M-

Cash Flow

Currency: CNY2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-23.35M17.01M-430.83K5.94M2.94M93.45M42.60M17.34M-2.20M-14.71M-15.95M-24.09M-4.95M-41.05M-6.54M-18.59M36.12M-33.75M-5.44M26.84M-6.34M-15.74M-17.97M1.95M-13.40M
Investing Cash Flow--3.70M-11.69M-214.93M-322.57M-36.91M-34.27M-165.42M-18.85M177.09M43.39M7.87M-6.98M3.96M-15.22M-171.31M-38.59M54.43M-47.54M133.45M-41.89M-88.00M-20.07M7.73M-7.95M-
Financing Cash Flow--10.84M-10.37M412.61M217.53M136.09M-93.09M-22.00M-23.28M-120.38M-48.86M-8.07M37.71M10.07M344.10M-22.26M-6.74M22.90M14.70M-14.70M-1.99M63.98M6.62M5.34M-3.74M-
Capital Expenditure03.70M10.91M207.96M339.78M49.31M16.24M69.60M21.33M10.04M12.36M12.24M20.98M21.34M53.33M23.97M11.74M15.26M26.40M4.50M1.39M23.29M7.77M10.03M10.07M6.46M
Free Cash Flow-19.64M6.10M-208.40M-333.84M-46.37M77.20M-27.00M-3.99M-12.24M-27.08M-28.19M-45.06M-26.29M-94.38M-30.51M-30.34M20.86M-60.16M-9.95M25.45M-29.63M-23.51M-28.00M-8.12M-19.86M
Dividends Paid-12.85M3.27M13.98M20.71M34.02M43.34M39.12M16.84M34.58M20.64M17.03M4.20M6.54M11.66M3.18M1.96M2.85M143.46K143.46K143.46K143.46K-16.27K-177.91K
FCF to OCF-84.13%35.85%48370.49%-5620.16%-1579.79%82.62%-63.38%-23.03%555.92%184.03%176.73%187.09%531.27%229.92%466.74%163.16%57.75%178.23%182.72%94.81%467.54%149.34%155.85%-416.79%148.24%
Dividend Paid to FCF-65.42%53.60%-6.71%-6.20%-73.36%56.13%-144.89%-421.74%-282.49%-76.23%-60.40%-9.32%-24.87%-12.36%-10.41%-6.46%13.64%-0.24%-1.44%0.56%-0.48%--0.06%--0.90%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 20, 2020Oct 30, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----------------------------------------------------
EPS Actual0.03-0.10-0.020.15-0.03-0.04-0.02-0.06-0.01-0.05-0.05-0.28-0.01-0.02-0.020.08-0.02-0.03-0.01-0.06-0.010.01-0.010.02-0.01-0.01-0.02-0.03-0.01-0.020.010.040.00-0.01-0.00-0.030.00-0.01-0.000.030.00-0.01-0.000.020.010.000.010.010.010.000.050.00-0.01
Surprise-----------------------------------------------------
Timing-----------------------------------------------------

Key Statistics & Ratios

Market Cap2.51B
Enterprise Value2.46B
Trailing P/E0.00
Forward P/E161.29
Price / Sales7.52
Price / Book3.74
EPS-0.18
Book Value1.29
Revenue (TTM)334.05M
Gross Profit (TTM)70.07M
EBITDA-9.60M
Profit Margin-27.87%
Operating Margin-3.34%
Return on Equity-12.48%
Return on Assets-1.53%
Shares Outstanding524.20M
Shares Float453.86M
Beta0.20
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20061×
0.38Jan 5, 2006
20031×
0.04Jul 9, 2003

Stock Splits

  • Jun 7, 20067:5
  • May 27, 20059:5